 | • レポートコード：MRC2Q12-18921 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、Casヌクレアーゼの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にCasヌクレアーゼのグローバル市場のxxx％を占める「Cas3」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「細胞モデル」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 Casヌクレアーゼの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのCasヌクレアーゼ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 Casヌクレアーゼのグローバル主要プレイヤーには、GenScript、Aldevron、Agilent、Horizon Discovery、Integrated DNA Technologies, Inc.、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 Casヌクレアーゼ市場は、種類と用途によって区分されます。世界のCasヌクレアーゼ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 Cas3、Cas9、Cas10 【用途別セグメント】 細胞モデル、疾患診断、汎用サイズスクリーニング、遺伝子治療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - Casヌクレアーゼ製品概要 - 種類別市場（Cas3、Cas9、Cas10） - 用途別市場（細胞モデル、疾患診断、汎用サイズスクリーニング、遺伝子治療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のCasヌクレアーゼ販売量予測2017-2028 - 世界のCasヌクレアーゼ売上予測2017-2028 - Casヌクレアーゼの地域別販売量 - Casヌクレアーゼの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別Casヌクレアーゼ販売量 - 主要メーカー別Casヌクレアーゼ売上 - 主要メーカー別Casヌクレアーゼ価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（Cas3、Cas9、Cas10） - Casヌクレアーゼの種類別販売量 - Casヌクレアーゼの種類別売上 - Casヌクレアーゼの種類別価格 ・用途別市場規模（細胞モデル、疾患診断、汎用サイズスクリーニング、遺伝子治療、その他） - Casヌクレアーゼの用途別販売量 - Casヌクレアーゼの用途別売上 - Casヌクレアーゼの用途別価格 ・北米市場 - 北米のCasヌクレアーゼ市場規模（種類別、用途別） - 主要国別のCasヌクレアーゼ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのCasヌクレアーゼ市場規模（種類別、用途別） - 主要国別のCasヌクレアーゼ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のCasヌクレアーゼ市場規模（種類別、用途別） - 主要国別のCasヌクレアーゼ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のCasヌクレアーゼ市場規模（種類別、用途別） - 主要国別のCasヌクレアーゼ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのCasヌクレアーゼ市場規模（種類別、用途別） - 主要国別のCasヌクレアーゼ市場規模（トルコ、サウジアラビア） ・企業情報 GenScript、Aldevron、Agilent、Horizon Discovery、Integrated DNA Technologies, Inc.、Thermo Fisher Scientific ・産業チェーン及び販売チャネル分析 - Casヌクレアーゼの産業チェーン分析 - Casヌクレアーゼの原材料 - Casヌクレアーゼの生産プロセス - Casヌクレアーゼの販売及びマーケティング - Casヌクレアーゼの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - Casヌクレアーゼの産業動向 - Casヌクレアーゼのマーケットドライバー - Casヌクレアーゼの課題 - Casヌクレアーゼの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cas Nuclease estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cas Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cas Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cas Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Cas Nuclease include GenScript, Aldevron, Agilent, Horizon Discovery, Integrated DNA Technologies, Inc. and Thermo Fisher Scientific, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cas Nuclease companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cas Nuclease market. Further, it explains the major drivers and regional dynamics of the global Cas Nuclease market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GenScript
Aldevron
Agilent
Horizon Discovery
Integrated DNA Technologies, Inc.
Thermo Fisher Scientific
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Cas Nuclease Segment by Type
Cas3
Cas9
Cas10
Cas Nuclease Segment by Application
Cell Model
Disease Diagnosis
Generic Size Screening
Gene Therapy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cas Nuclease market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cas Nuclease market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cas Nuclease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cas Nuclease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cas Nuclease revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cas Nuclease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cas Nuclease revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GenScript, Aldevron, Agilent, Horizon Discovery, Integrated DNA Technologies, Inc. and Thermo Fisher Scientific, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cas Nuclease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cas Nuclease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cas Nuclease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cas Nuclease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cas3
1.2.3 Cas9
1.2.4 Cas10
1.3 Market by Application
1.3.1 Global Cas Nuclease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cell Model
1.3.3 Disease Diagnosis
1.3.4 Generic Size Screening
1.3.5 Gene Therapy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cas Nuclease Market Perspective (2017-2028)
2.2 Cas Nuclease Growth Trends by Region
2.2.1 Cas Nuclease Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cas Nuclease Historic Market Size by Region (2017-2022)
2.2.3 Cas Nuclease Forecasted Market Size by Region (2023-2028)
2.3 Cas Nuclease Market Dynamics
2.3.1 Cas Nuclease Industry Trends
2.3.2 Cas Nuclease Market Drivers
2.3.3 Cas Nuclease Market Challenges
2.3.4 Cas Nuclease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cas Nuclease Players by Revenue
3.1.1 Global Top Cas Nuclease Players by Revenue (2017-2022)
3.1.2 Global Cas Nuclease Revenue Market Share by Players (2017-2022)
3.2 Global Cas Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cas Nuclease Revenue
3.4 Global Cas Nuclease Market Concentration Ratio
3.4.1 Global Cas Nuclease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cas Nuclease Revenue in 2021
3.5 Cas Nuclease Key Players Head office and Area Served
3.6 Key Players Cas Nuclease Product Solution and Service
3.7 Date of Enter into Cas Nuclease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cas Nuclease Breakdown Data by Type
4.1 Global Cas Nuclease Historic Market Size by Type (2017-2022)
4.2 Global Cas Nuclease Forecasted Market Size by Type (2023-2028)
5 Cas Nuclease Breakdown Data by Application
5.1 Global Cas Nuclease Historic Market Size by Application (2017-2022)
5.2 Global Cas Nuclease Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cas Nuclease Market Size (2017-2028)
6.2 North America Cas Nuclease Market Size by Type
6.2.1 North America Cas Nuclease Market Size by Type (2017-2022)
6.2.2 North America Cas Nuclease Market Size by Type (2023-2028)
6.2.3 North America Cas Nuclease Market Share by Type (2017-2028)
6.3 North America Cas Nuclease Market Size by Application
6.3.1 North America Cas Nuclease Market Size by Application (2017-2022)
6.3.2 North America Cas Nuclease Market Size by Application (2023-2028)
6.3.3 North America Cas Nuclease Market Share by Application (2017-2028)
6.4 North America Cas Nuclease Market Size by Country
6.4.1 North America Cas Nuclease Market Size by Country (2017-2022)
6.4.2 North America Cas Nuclease Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cas Nuclease Market Size (2017-2028)
7.2 Europe Cas Nuclease Market Size by Type
7.2.1 Europe Cas Nuclease Market Size by Type (2017-2022)
7.2.2 Europe Cas Nuclease Market Size by Type (2023-2028)
7.2.3 Europe Cas Nuclease Market Share by Type (2017-2028)
7.3 Europe Cas Nuclease Market Size by Application
7.3.1 Europe Cas Nuclease Market Size by Application (2017-2022)
7.3.2 Europe Cas Nuclease Market Size by Application (2023-2028)
7.3.3 Europe Cas Nuclease Market Share by Application (2017-2028)
7.4 Europe Cas Nuclease Market Size by Country
7.4.1 Europe Cas Nuclease Market Size by Country (2017-2022)
7.4.2 Europe Cas Nuclease Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cas Nuclease Market Size (2017-2028)
8.2 Asia-Pacific Cas Nuclease Market Size by Type
8.2.1 Asia-Pacific Cas Nuclease Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cas Nuclease Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cas Nuclease Market Share by Type (2017-2028)
8.3 Asia-Pacific Cas Nuclease Market Size by Application
8.3.1 Asia-Pacific Cas Nuclease Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cas Nuclease Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cas Nuclease Market Share by Application (2017-2028)
8.4 Asia-Pacific Cas Nuclease Market Size by Region
8.4.1 Asia-Pacific Cas Nuclease Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cas Nuclease Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cas Nuclease Market Size (2017-2028)
9.2 Latin America Cas Nuclease Market Size by Type
9.2.1 Latin America Cas Nuclease Market Size by Type (2017-2022)
9.2.2 Latin America Cas Nuclease Market Size by Type (2023-2028)
9.2.3 Latin America Cas Nuclease Market Share by Type (2017-2028)
9.3 Latin America Cas Nuclease Market Size by Application
9.3.1 Latin America Cas Nuclease Market Size by Application (2017-2022)
9.3.2 Latin America Cas Nuclease Market Size by Application (2023-2028)
9.3.3 Latin America Cas Nuclease Market Share by Application (2017-2028)
9.4 Latin America Cas Nuclease Market Size by Country
9.4.1 Latin America Cas Nuclease Market Size by Country (2017-2022)
9.4.2 Latin America Cas Nuclease Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cas Nuclease Market Size (2017-2028)
10.2 Middle East & Africa Cas Nuclease Market Size by Type
10.2.1 Middle East & Africa Cas Nuclease Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cas Nuclease Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cas Nuclease Market Share by Type (2017-2028)
10.3 Middle East & Africa Cas Nuclease Market Size by Application
10.3.1 Middle East & Africa Cas Nuclease Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cas Nuclease Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cas Nuclease Market Share by Application (2017-2028)
10.4 Middle East & Africa Cas Nuclease Market Size by Country
10.4.1 Middle East & Africa Cas Nuclease Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cas Nuclease Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Cas Nuclease Introduction
11.1.4 GenScript Revenue in Cas Nuclease Business (2017-2022)
11.1.5 GenScript Recent Developments
11.2 Aldevron
11.2.1 Aldevron Company Details
11.2.2 Aldevron Business Overview
11.2.3 Aldevron Cas Nuclease Introduction
11.2.4 Aldevron Revenue in Cas Nuclease Business (2017-2022)
11.2.5 Aldevron Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Cas Nuclease Introduction
11.3.4 Agilent Revenue in Cas Nuclease Business (2017-2022)
11.3.5 Agilent Recent Developments
11.4 Horizon Discovery
11.4.1 Horizon Discovery Company Details
11.4.2 Horizon Discovery Business Overview
11.4.3 Horizon Discovery Cas Nuclease Introduction
11.4.4 Horizon Discovery Revenue in Cas Nuclease Business (2017-2022)
11.4.5 Horizon Discovery Recent Developments
11.5 Integrated DNA Technologies, Inc.
11.5.1 Integrated DNA Technologies, Inc. Company Details
11.5.2 Integrated DNA Technologies, Inc. Business Overview
11.5.3 Integrated DNA Technologies, Inc. Cas Nuclease Introduction
11.5.4 Integrated DNA Technologies, Inc. Revenue in Cas Nuclease Business (2017-2022)
11.5.5 Integrated DNA Technologies, Inc. Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Cas Nuclease Introduction
11.6.4 Thermo Fisher Scientific Revenue in Cas Nuclease Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Cas Nuclease Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cas3
Table 3. Key Players of Cas9
Table 4. Key Players of Cas10
Table 5. Global Cas Nuclease Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Cas Nuclease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cas Nuclease Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cas Nuclease Market Share by Region (2017-2022)
Table 9. Global Cas Nuclease Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cas Nuclease Market Share by Region (2023-2028)
Table 11. Cas Nuclease Market Trends
Table 12. Cas Nuclease Market Drivers
Table 13. Cas Nuclease Market Challenges
Table 14. Cas Nuclease Market Restraints
Table 15. Global Cas Nuclease Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cas Nuclease Revenue Share by Players (2017-2022)
Table 17. Global Top Cas Nuclease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cas Nuclease as of 2021)
Table 18. Ranking of Global Top Cas Nuclease Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cas Nuclease Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cas Nuclease Product Solution and Service
Table 22. Date of Enter into Cas Nuclease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cas Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cas Nuclease Revenue Market Share by Type (2017-2022)
Table 26. Global Cas Nuclease Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cas Nuclease Revenue Market Share by Type (2023-2028)
Table 28. Global Cas Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cas Nuclease Revenue Share by Application (2017-2022)
Table 30. Global Cas Nuclease Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cas Nuclease Revenue Share by Application (2023-2028)
Table 32. North America Cas Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Cas Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Cas Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Cas Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Cas Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Cas Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Cas Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Cas Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Cas Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Cas Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Cas Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Cas Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Cas Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Cas Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Cas Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Cas Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Cas Nuclease Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Cas Nuclease Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Cas Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Cas Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Cas Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Cas Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Cas Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Cas Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Cas Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Cas Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cas Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cas Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Cas Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Cas Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 62. GenScript Company Details
Table 63. GenScript Business Overview
Table 64. GenScript Cas Nuclease Product
Table 65. GenScript Revenue in Cas Nuclease Business (2017-2022) & (US$ Million)
Table 66. GenScript Recent Developments
Table 67. Aldevron Company Details
Table 68. Aldevron Business Overview
Table 69. Aldevron Cas Nuclease Product
Table 70. Aldevron Revenue in Cas Nuclease Business (2017-2022) & (US$ Million)
Table 71. Aldevron Recent Developments
Table 72. Agilent Company Details
Table 73. Agilent Business Overview
Table 74. Agilent Cas Nuclease Product
Table 75. Agilent Revenue in Cas Nuclease Business (2017-2022) & (US$ Million)
Table 76. Agilent Recent Developments
Table 77. Horizon Discovery Company Details
Table 78. Horizon Discovery Business Overview
Table 79. Horizon Discovery Cas Nuclease Product
Table 80. Horizon Discovery Revenue in Cas Nuclease Business (2017-2022) & (US$ Million)
Table 81. Horizon Discovery Recent Developments
Table 82. Integrated DNA Technologies, Inc. Company Details
Table 83. Integrated DNA Technologies, Inc. Business Overview
Table 84. Integrated DNA Technologies, Inc. Cas Nuclease Product
Table 85. Integrated DNA Technologies, Inc. Revenue in Cas Nuclease Business (2017-2022) & (US$ Million)
Table 86. Integrated DNA Technologies, Inc. Recent Developments
Table 87. Thermo Fisher Scientific Company Details
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Cas Nuclease Product
Table 90. Thermo Fisher Scientific Revenue in Cas Nuclease Business (2017-2022) & (US$ Million)
Table 91. Thermo Fisher Scientific Recent Developments
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cas Nuclease Market Share by Type: 2021 VS 2028
Figure 2. Cas3 Features
Figure 3. Cas9 Features
Figure 4. Cas10 Features
Figure 5. Global Cas Nuclease Market Share by Application: 2021 VS 2028
Figure 6. Cell Model Case Studies
Figure 7. Disease Diagnosis Case Studies
Figure 8. Generic Size Screening Case Studies
Figure 9. Gene Therapy Case Studies
Figure 10. Others Case Studies
Figure 11. Cas Nuclease Report Years Considered
Figure 12. Global Cas Nuclease Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Cas Nuclease Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Cas Nuclease Market Share by Region: 2021 VS 2028
Figure 15. Global Cas Nuclease Market Share by Players in 2021
Figure 16. Global Top Cas Nuclease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cas Nuclease as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Cas Nuclease Revenue in 2021
Figure 18. North America Cas Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Cas Nuclease Market Size Market Share by Type (2017-2028)
Figure 20. North America Cas Nuclease Market Size Market Share by Application (2017-2028)
Figure 21. North America Cas Nuclease Market Size Share by Country (2017-2028)
Figure 22. United States Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Cas Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Cas Nuclease Market Size Market Share by Type (2017-2028)
Figure 26. Europe Cas Nuclease Market Size Market Share by Application (2017-2028)
Figure 27. Europe Cas Nuclease Market Size Share by Country (2017-2028)
Figure 28. Germany Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Cas Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Cas Nuclease Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Cas Nuclease Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Cas Nuclease Market Size Share by Region (2017-2028)
Figure 38. China Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Cas Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Cas Nuclease Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Cas Nuclease Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Cas Nuclease Market Size Share by Country (2017-2028)
Figure 48. Mexico Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Cas Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Cas Nuclease Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Cas Nuclease Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Cas Nuclease Market Size Share by Country (2017-2028)
Figure 54. Turkey Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Cas Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. GenScript Revenue Growth Rate in Cas Nuclease Business (2017-2022)
Figure 58. Aldevron Revenue Growth Rate in Cas Nuclease Business (2017-2022)
Figure 59. Agilent Revenue Growth Rate in Cas Nuclease Business (2017-2022)
Figure 60. Horizon Discovery Revenue Growth Rate in Cas Nuclease Business (2017-2022)
Figure 61. Integrated DNA Technologies, Inc. Revenue Growth Rate in Cas Nuclease Business (2017-2022)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cas Nuclease Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed